Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients.
| Image |  |
|---|---|
| Description | scientific article published on 4 November 2013 |
| Author/s |
author: Oliver Ottmann Uwe Platzbecker Gerhard Ehninger Haifa Kathrin Al-Ali |
| Publication date | November 4, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |